Formulating and Implementing Pharmaceutical Pricing Policies

Dr. Zaheer Babar is a Professor in Medicines and Healthcare at the Department of Pharmacy and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. He is globally known for his work in pharmaceutical policy, access to medicines, and issues related to medicines pricing. In 2018, Health Action International (HAI) stated that he is the leading expert in access to medicines, globally. In the last 22 years, Dr. Babar has worked at Universities in Malaysia, New Zealand, and the UK, and this experience has given him an in-depth understanding of global pharmaceutical public health.

1. An update on pharmaceutical pricing policies: latest research and evidence synthesis 2. Research methods used in pharmaceutical pricing research 3. Implementation of pharmaceutical pricing policies in NZ: Lessons learned 4. Australia's progress in pharmaceutical pricing policies 5. Components of a successful pricing policy in high-income countries 6. Outlining the components of a pricing policy for the US: a proposal 7. Lessons learned from China on medicine pricing policies 8. Synthesis chapter on EU Pharmaceutical pricing policies 9. Challenges in Low and Middle-Income Countries regarding pharmaceutical pricing policies 10. South Africa's medicine pricing policies: implementation strategies and models 11. Pharmaceutical pricing policies in countries with price control (Pakistan, India, Bangladesh): lessons learned 12. Challenges in the implementation of pharmaceutical pricing policies 13. Issues with medicine pricing data about pharmaceutical pricing policies in LMICs 14. Optimal pharmaceutical pricing policies in low and middle-income countries 15. Formulating a medicines pricing policy of a country: essential components, what to include 16. Synthesis, conclusion, and future recommendation